Today: 9 April 2026
Google stock price today: Alphabet GOOG ticks up after hours on EU DMA move, earnings ahead
28 January 2026
2 mins read

Google stock price today: Alphabet GOOG ticks up after hours on EU DMA move, earnings ahead

New York, January 27, 2026, 17:39 EST — After-hours

  • Alphabet Class C shares (GOOG) gained roughly 0.4% after hours.
  • EU regulators have launched Digital Markets Act proceedings targeting access to Google Search data and Gemini AI features.
  • Investors are zeroing in on Alphabet’s Feb. 4 earnings for clues on cloud and AI performance.

Alphabet’s non-voting Class C shares (GOOG) gained roughly 0.4%, closing at $335 in after-hours trading Tuesday, following the European Union’s launch of a new probe targeting broader access to certain Google services. During regular hours, the stock fluctuated between $333.94 and $338.80.

Timing is crucial. As Big Tech earnings season ramps up, all eyes turn to Alphabet next week, where its AI strategy will get more scrutiny than it has in years.

Investors are demanding clear evidence that Alphabet’s new AI features boost revenue without squeezing margins. They’re also focused on the costs Alphabet faces to stay competitive, and whether regulatory hurdles might force product adjustments just as those investments begin to impact earnings.

The European Commission launched two “specification proceedings” under the Digital Markets Act, clarifying how the rules apply. One targets rival AI providers seeking access to features within Google’s Gemini services; the other demands access to anonymised Google Search data, including ranking, query, click, and view details. Google’s senior competition counsel Clare Kelly responded, saying, “Android is open by design,” but warned that tighter rules risk “compromising user privacy, security, and innovation.” Reuters

Just one day before, Google agreed to a $68 million settlement in a proposed class action lawsuit claiming its voice assistant recorded and shared private conversations without consent after false activations, court documents show. The deal now awaits approval from U.S. District Judge Beth Labson Freeman in San Jose, California. Reuters

The regulatory pressure intensifies just as the AI sector moves from hype to earnings reports. Alphabet has stood out among the top performers, with high expectations now built in.

Analysts forecast that Microsoft, Meta, Amazon, and Alphabet will boost AI spending by roughly 30%, pushing total investments past $500 billion this year and raising the stakes for tangible returns. Alphabet’s stock jumped about 29% in Q4 2025, buoyed by strong reception of Google’s Gemini 3 model and a new deal powering Apple’s revamped Siri. David Wagner, head of equities at Aptus Capital Advisors, said, “Alphabet has the upper hand in the AI race.” LSEG data suggests Google Cloud’s growth likely accelerated to around 35% in the October-December quarter, with Alphabet’s revenue projected to climb 15.5% to $111.37 billion. Reuters

Traders eye Alphabet’s report for signs on ad pricing and cloud growth, plus any news on integrating AI into Search. Forecasts on capital spending could prove just as crucial as revenue numbers.

The risk lies in the numbers leaving little margin for error. A weakened ad market, slower cloud expansion, or signs that AI products are eating into traditional search clicks could quickly shift sentiment. On top of that, the EU’s ongoing process introduces fresh uncertainty over how Google will need to share critical data and features.

Alphabet announced it will release its fourth-quarter and full-year 2025 earnings on February 4, followed by a conference call at 4:30 p.m. Eastern. The earnings report will be published before the call. abc.xyz

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Boeing stock slips after earnings: Jeppesen windfall lifts profit, but core loss bites
Previous Story

Boeing stock slips after earnings: Jeppesen windfall lifts profit, but core loss bites

CVS stock price dives 14% after CMS Medicare Advantage rate proposal; what investors watch next
Next Story

CVS stock price dives 14% after CMS Medicare Advantage rate proposal; what investors watch next

Go toTop